Form 4: Sabra Health Care REIT Director Acquires Additional Stock Units Through Dividend Equivalent Payments

Sentiment:

SEC Form 4 Filing


Jeffrey A. Malehorn, a director of Sabra Health Care REIT, acquired 1,040 common stock units through dividend equivalent payments on February 29, 2024, increasing his total holdings to 82,573 shares.

Summary

  • On February 29, 2024, Jeffrey A. Malehorn, a director of Sabra Health Care REIT, Inc. (SBRA), acquired 1,040 common stock units.
  • The acquisition was a result of dividend equivalent payments on previously granted stock units under the company's 2009 Performance Incentive Plan.
  • The price per share was $0.
  • Following the transaction, Malehorn's total beneficial ownership in Sabra Health Care REIT amounts to 82,573 shares, including unvested and deferred stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. There's no indication of significant positive or negative implications.

Positives

  • The acquisition of stock units by a director demonstrates confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction reflects standard compensation practices within REITs and other publicly traded companies.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it is a standard part of director compensation.

Key Dates

DateDescription
02/29/2024Date of transaction: Jeffrey A. Malehorn acquired 1,040 common stock units.
03/04/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.